Showing 105 of 105on this page. Filters & sort apply to loaded results; URL updates for sharing.105 of 105 on this page
EpimAb Biotherapeutics Achieves Key Milestone with Lead Cancer Program ...
EpimAb Biotherapeutics Submits Hong Kong IPO Application as Biotech ...
EpimAb Biotherapeutics Announces FDA Clearance of its IND Application ...
EpimAb Biotherapeutics and Innovent Biologics Announce Multi-Target ...
Company Culture | EpimAb
EpimAb Biotherapeutics Appoints Industry Veteran Bin Peng as Chief ...
About | EpimAb
FIT-Ig® | EpimAb
China's EpimAb raises $25m in Series A round led by Oriza Seed
EpimAb Biotherapeutics - 2026 Company Profile, Team, Funding ...
EpimAb Biotherapeutics completes Series B financing - Chinadaily.com.cn
PipeLine | EpimAb
Home | EpimAb
Almirall and EpimAb partner to develop bispecific antibody therapies ...
Shanghai’s EpimAb Completes $74 Million Series B for Bi-Specific ...
EpimAb Biotherapeutics to Showcase Innovations at SITC 2024 - Investors ...
EpimAb People | EpimAb
EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal ...
Medigene and EpimAb Biotherapeutics: A Powerful Alliance for TCR-Guided ...
EpimAb Biotherapeutics Updates IPO Filing: China’s TCE Pioneer Turns ...
Our Science | EpimAb Biotherapeutics | Immunolo...
Medigene and EpimAb Partner to Advance Off-the-Shelf TCR-TCE Therapies ...
EpimAb Biotherapeutics, Inc. on LinkedIn: #PEGS22 #bispecific #innovation
epimab THOR Serum Protein GEL Components - YouTube
Epimab Biotherapeutics raises $120M series C to advance clinical ...
Medigene and EpimAb Biotherapeutics Enter into a Co-Development ...
CEO EPIMAB BIOTHERAPEUTICS – Dr. Chengbin Wu – The Business Insight
News | EpimAb
Partnering Strategy | EpimAb
Medigene and EpimAb to Develop T Cell Engagers for Solid Tumors
Events | EpimAb
Asher raises $55M; Roche's Huntington's trial; EpimAb bags $120M
Week In Review: EpimAb Sells T-Cell Engager In $635m Deal | Seeking Alpha
EpimAb Biotherapeutics, Inc. (上海岸迈生物科技有限公司) - 药物管线_专利_临床试验_投融营收_最新药物 ...
Epimab sells bispecific T-cell engager to Juri in $210M deal | BioWorld
Acuerdo entre Almirall y EpimAb Biotherapeutics
Medigene and Epimab to codevelop TCR-guided T-cell engagers | BioWorld
AlmirallAlmirall partners with EpimAb to develop bispecific antibodies
Medigene and EpimAb to co-develop T cell engagers
EpimAb Biotherapeutics and Vignette Bio collaborate | Biotechnology ...
EpimAb Biotherapeutics, Inc. (上海岸迈生物科技有限公司) - 药物管线_专利_临床试验_投融营收_最新药物:甲 ...
Candid partners with EpimAb to develop T-cell engager candidates
Management Team | EpimAb
Chengbin Wu - CEO & Founder, EpimAb Biotherapeutics
Job opportunity | EpimAb
Board of Directors | EpimAb
Candid and EpimAb Collaborate to Develop T-Cell Engagers for Autoimmune ...
Chinese Biopharmaceutical Start-Up EpimAb Closes $74M Series B Round ...
FDA clears EpimAb’s IND for trial of cancer combo therapy
TCG Labs' Juri Biosciences Secures $210M Deal for EpimAb’s Prostate ...
Fabs-in-tandem Immunoglobulin And Uses Thereof WU; Chengbin [EpimAb ...
6 Takeaways from EpimAb's $210 Million NewCo - Case Study - Unibest ...
国内潜力双抗平台巡礼：EpimAb|投资|生物|临床|EMB-|药物|-健康界
Chinese biotech firm boosts funding, plans IPO next to catch European ...
June 8 2023
Fabs-in-tandem immunoglobulin and uses thereof Patent Grant Wu Dec ...
Top 40 Biopharma Startups in 2024
Almirall signs $210M deal to use EpimAb's platform to develop ...
